Zai Lab Limited (NASDAQ:ZLAB) and NovoCure Limited (NASDAQ:NVCR) revealed landmark results from the Phase 3 PANOVA-3 trial at ...

Actuate Therapeutics, Inc. (NASDAQ:ACTU) has announced breakthrough results from its Phase 2 trial of elraglusib combined ...

Shareholders of Black Spade Acquisition II Co (NASDAQ:BSII) have approved the proposed business combination with The ...

Grindr Inc. (NYSE:GRND) has officially launched its real-time discovery tool, Right Now, across all global markets.

Guardant Health, Inc. (NASDAQ:GH) and research collaborators have unveiled results from the largest study to date on ...

Xilio Therapeutics, Inc. (NASDAQ: XLO) announced promising updated Phase 2 results for its investigational therapy ...

BofA analyst Craig Bijou reiterated a Buy rating on Cooper Companies, Inc. (NASDAQ:COO), lowering the associated price target ...

The analyst based the rating on COO exceeding expectations, reporting a 6% year-over-year revenue growth, which amounted to ...

Perspective Therapeutics, Inc. (NYSE:CATX) has announced encouraging interim results from its ongoing Phase 1/2a clinical ...